Kinetics Medical Fund Class A (KRXAX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund normally invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, generally, with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.


1 month+2.88% 3 years+25.00%
3 months+11.18% 5 years+17.09%
1 year+13.25% Since inception+6.92%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+17.09%+21.57%
Expense ratio2.34%1.45%
Risk 5 year sharpe ratio1.151.48
Net assets$28.3M$3.4B
Average market cap$34.6B$35.3B
Average P/E28.026.2
Portfolio turnover12%12%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyKinetics
Fund manager & tenureBruce Abel / 13 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00


U.S. stock64.50%
International stock35.44%
Fixed income0.06%
Top 5 Sectors
Portfolio weighting
Healthcare 94.65%
Industrial materials 4.23%
Business service 1.12%
Telecommunication 0.01%
Consumer goods 0.00%
Top 10 Holdings
Portfolio weighting
BIIB Biogen9.26%
BMY Bristol-Myers Squibb6.72%
NVS Novartis6.54%
-- 6.15%
SHPG Shire6.00%
JNJ Johnson & Johnson5.76%
LLY Eli Lilly and Co5.76%
SNY Sanofi5.67%
PFE Pfizer5.25%
AMRI Albany Molecular Research Inc4.77%

To view my watchlist

Not a member yet?

Sign up now for a free account